HCPCS Level II J9021: Injection, asparaginase (Rylaze), 0.1 mg
HCPCS Level II code J9021 describes administration of recombinant asparaginase (Rylaze) measured per 0.1 mg, representing a parenteral chemotherapy or biologic injection typically billed for inpatient or outpatient oncology settings such as hospital infusion centers or clinic infusion suites; this code is used to report the specific drug product and unit-of-measure for clinical documentation and claims processing.
Customize your policy alerts
Sign up for hcpcs J9021 policy alerts
Get alerted when payer policies referencing J9021 are released or updated.
Monitor payer policy activity